France· FR:61070180

APREPITANT EG 80 mg, gélule

A aprepitant product containing aprépitant, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A04AD12

Checked against Base de données publique des médicaments — BDPM (France) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about aprépitantAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Aprepitant is registered in 17 of 19 countries.

Countries holding a registration under ATC A04AD12 (aprepitant), each read from that country’s own register.

This record: France, from Base de données publique des médicaments — BDPM (France)
9 of them publish a price we can compare per daily dose

Search aprepitant products by name

Aprepitant · ATC A04AD12

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aprepitant costs, country by country.

Normalised to the WHO defined daily dose (165 mg), the median price runs from $0.40 in Finland to $157.48 in United States — a ×394 gap.

France: $33.15 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Aprepitant · price per daily dose (165 mg)

USD · FX 28 Sept 2026

US United States$157.48 (acquisition cost)
CH Switzerland$73.26
FR France$33.15
FI Finland$0.40

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)

Active substance: APRÉPITANT
Manufacturer: EG LABO - LABORATOIRES EUROGENERICS
Country: France (FR)
ATC code: A04AD12
ATC class: Aprepitant
Defined daily dose: 165 mg, O
Reimbursed: Yes
Source register: Base de données publique des médicaments — BDPM (France)
Last checked: September 12, 2026

Packs & prices · 1

1 priced

cip13
3400930169759
2 plaquettes aluminium OPA : polyamide orientÃ© PVC de 1 gÃ©lule
EUR 14.84

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

583 interactions on record for aprepitant.

Graded by severity as the source publishes them — 73 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check aprepitant against other medicines How interaction checks work

Aprepitant · interactions on record

583 records

73 severe
380 moderate
25 minor
104 info

Most severe, free to view

CisaprideA03FA02severe
NaloxegolA06AH03severe
EliglustatA16AX10severe
LonafarnibA16AX20severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aprepitant in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aprepitant products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Aprepitant Accord, Aprepitant Ratiopharm
Belgium · Aprepitant Sandoz, Aprepitant Teva
Cyprus · Atanto, Endrem
Czechia · Aprepitant Accord, Aprepitant Sandoz
Germany · Aprepilor, Aprepitant Al
Denmark · Aprepitant "medical Valley", Aprepitant Medical Valley
Estonia · Aprepitant Sandoz
Spain · Aprepitant Accord, Aprepitant Qilu
Finland · Aprepitant Stada
United Kingdom (Northern Ireland) · Aprepitant, Aprepitant Accord
Greece · Aprepitant Win Medica, Atanto
Croatia · Aprepitant Alpha-Medical, Aprepitant Sandoz
Hungary · Aprepitant Pharmacenter, Aprepitant Q Pharma
Ireland · Aprepitant Accord
Iceland · Aprepitant Medical Valley, Aprepitant Stada
Italy · Aprepitant Accord, Aprepitant Teva
Liechtenstein · Emend
Lithuania · Aprepitant Sandoz
Latvia · Aprepitant Sandoz
Netherlands · Aprepitant Accord, Aprepitant Aurobind
Norway · Emend
Poland · Aprepitant Accord, Aprepitant Sandoz
Portugal · Aprepitant Generis
Sweden · Aprepitant Medical Valley, Aprepitant Stada
Slovenia · Aprepitant Teva
Slovakia · Aprepitant, Aprepitant Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/0d3accfd-ed11-4286-912c-4a605cd5a87b
GET /v1/drugs/0d3accfd-ed11-4286-912c-4a605cd5a87b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61070180",
  "date_amm": "2019-01-14",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "APRÉPITANT",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

API reference MCP server Plans

See everything about aprepitant.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console